Arkolith/Insider Trading/MNPR/Form 4

Tactic Pharma LLC

Chief Executive Officer, Director, 10% OwnerMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Sep 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$35.0M
Net Open-Market Flow
-$35.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 24, 2025Sell(S)550K$63.61$35.0M272K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-029925) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML